Making drugs out of oligonucleotides: a brief review and perspective.
about
2'-O-[2-[(N,N-dimethylamino)oxy]ethyl]-modified oligonucleotides inhibit expression of mRNA in vitro and in vivoMapping of accessible sites for oligonucleotide hybridization on hepatitis delta virus ribozymesChemical approaches to control gene expression.Oligonucleotides containing 9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-adenine and -guanine: synthesis, hybridization and antisense properties.Pyrophosphoryl derivatives of 1-(2-deoxy-3-O-phosphono-methyl-beta- and -alpha-D-erythro-pentofuranosyl)thymine: synthesis and substrate properties towards some DNA polymerases.Optimizations of siRNA design for the activation of gene transcription by targeting the TATA-box motif.Novel drugs targeting the androgen receptor pathway in prostate cancer.A brief history, status, and perspective of modified oligonucleotides for chemotherapeutic applications.Quantum mechanical studies of DNA and LNA.Expanding the design horizon of antisense oligonucleotides with alpha-L-LNA.A new "native ligation" procedure for peptide-oligonucleotide conjugation.Antisense properties of 2'-O-dimethylaminooxyethyl (2'-O-DMAOE) oligonucleotides.FTIR and UV spectroscopy studies of triplex formation between pyrimidine methoxyethylphosphoramidates alpha-oligodeoxynucleotides and ds DNA targets.Novel synthesis of 2'-O modified oligonucleotides by solid phase fragment condensation.On the in vitro and in vivo Properties of Four Locked Nucleic Acid Nucleotides Incorporated into an Anti-H-Ras Antisense Oligonucleotide
P2860
Q30048726-0C6A403B-A3CA-49A1-A645-F756B8D336C7Q30850742-AD6E1984-3DFA-49F7-8740-CC2F7839C24EQ30971784-2A10C7E9-4D00-4D8C-847E-DD1543BA09E0Q31996937-A6556BED-814B-476E-8925-4F2E2C29EB9AQ31996963-86F9189E-A2D5-4364-ACAB-00993D9494B5Q34252830-67161635-0A00-40B3-82AC-CC89D6496699Q34395777-48D74126-D707-4071-B42B-17D91B28C084Q37144630-0A15A368-4B17-41CC-89CD-DD0BC219FB5FQ38405255-7DB5A6C8-8442-4851-A413-DA90750D6629Q40240405-63F4D81C-5CA8-47EA-BDF1-8A3B43CE1A98Q43741969-2B54DF36-B4D0-4444-B5A0-96EF0B830012Q43815880-7368D2B6-B039-4141-B102-3E225970DD93Q44002576-A945E4D0-9D9A-4AA9-AD7C-405BD8C2D953Q51810772-4100A5DB-9AA2-4C8B-A21D-8CC139350185Q58183450-6C0F9FA0-D8E4-40FE-9755-FC8ABF66CE56
P2860
Making drugs out of oligonucleotides: a brief review and perspective.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
name
Making drugs out of oligonucleotides: a brief review and perspective.
@ast
Making drugs out of oligonucleotides: a brief review and perspective.
@en
type
label
Making drugs out of oligonucleotides: a brief review and perspective.
@ast
Making drugs out of oligonucleotides: a brief review and perspective.
@en
prefLabel
Making drugs out of oligonucleotides: a brief review and perspective.
@ast
Making drugs out of oligonucleotides: a brief review and perspective.
@en
P2860
P1476
Making drugs out of oligonucleotides: a brief review and perspective.
@en
P2093
P2860
P304
P356
10.1080/07328319908044652
P577
1999-06-01T00:00:00Z